Immunogenicity of Therapeutic Proteins

Industry practices in immunogenicity assessment are becoming more unified though challenges still exist in terms of technology and reduction to practice. This conference aims to review key aspects of assay development and validation as well as to discuss challenges in implementation of these assays, data interpretation and relevance to clinical outcomes.